Free press releases distribution network?

Agency / Source: GenericsWeb Pty Ltd | Ark Patent Intelligence

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Generic Candesartan Launch Opportunity - Prodrug Patent Expiration in 2012 - GenericsWeb, the leader in established pharmaceutical patent analysis and searching, recently published an article based on its proprietary Pipeline Patent Intelligence that analyses opportunities in launching generic versions of Atacand®
Generic Candesartan Launch Opportunity - Prodrug Patent Expiration in 2012

 

PRZOOM - /newswire/ - Sydney, New South Wales, Australia, 2011/08/23 - GenericsWeb, the leader in established pharmaceutical patent analysis and searching, recently published an article based on its proprietary Pipeline Patent Intelligence that analyses opportunities in launching generic versions of Atacand®.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Intellectual Property/Invention Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Marketed by AstraZeneca and Takeda, Candesartan cilexetil is indicated for the treatment of hypertension and heart failure, with sales of US $1.5bn in 2010. Candesartan cilexetil is currently available in oral tablet formulations and in oral tablet fixed dose formulations in combination with Hydrochlorothiazide (Atacand HCT®).

The article by GenericsWeb highlights thPatent protection of the candesartan cilexetil prodrug molecule remains in force in Europe via Supplementary Protection Certificates and national patent extensions in other major territories until 2012-2013.

• Patent protection has expired in Canada and generics are available from Apotex, Sandoz and Teva, and generics have been identified in Australia despite the extended molecule patent remaining in force.
• In all major territories where Candesartan has been marketed, the data and marketing exclusivity have already expired thus are not a factor for generic competition.
• Patents protecting the combination product with Hydrochlorothiazide (HCTZ) are identified in Canada, Europe and the US; however the granted European equivalent has recently been revoked and the Canadian patent is undergoing litigation.
• In the US, tentative FDA approvals for generic Atacand have been granted and several Paragraph IV filings have been identified relating generic Atacand and Atacand HCT.
• Generic companies KRKA and Teva appear in the top five applicants for patents relating to Candesartan.
• Since the initial and on-going approvals of Atacand HCT, several generic companies have submitting patent filings relating to combination products and their various uses.

GenericsWeb notes that: “Currently a barrier to generic competition, the expiry of the prodrug molecule patents in 2012 in Europe and the US means that generic competition to Candesartan is likely to be very strong, evidenced by the fact that generic Candesartan appeared in Canada only days after the expiry of the Canadian molecule patent.”

Generic combinations of Candesartan cilexetil and HCTZ may be prevented until 2014; however this will depend on the outcome of litigation in Canada, which is currently on-going. Since the revocation of the equivalent European patent, the outcome of new pending European applications concerning the combination is of great importance when considering generic Atacand HCT, as these are unlikely to proceed unopposed by major generic manufacturers.”

About GenericsWeb – The search is over

GenericsWeb (genericsweb.com), the leader in pharmaceutical patent analysis and searching holds an impeccable track record in providing quality patent information, and has allowed numerous pharmaceutical companies to successfully navigate intellectual property hazards. GenericsWeb is headquartered in Sydney, Australia, with offices in North America and Europe. All staff are highly skilled and experienced internationally and have extensive experience in pharmaceutical sciences and patent searching.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Intellectual Property/Invention Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GenericsWeb Pty Ltd | Ark Patent Intelligence

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Intellectual Property/Invention articles,
CATCH Visitors via Your Competitors Announcements!


Generic Candesartan Launch Opportunity - Prodrug Patent Expiration in 2012

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Yoann Bretonnet - GenericsWeb.com 
+61(2) 9262 7696
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GenericsWeb Pty Ltd | Ark Patent Intelligence securities in any jurisdiction including any other companies listed or named in this release.

Intellectual Property/Invention via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GenericsWeb Pty Ltd | Ark Patent Intelligence / Company Profile


Read Intellectual Property/Invention Most Recent Related Press Releases:

Embrionix to Bring the World’s First JPEG 2000 SFP Module Powered by IntoPIX Technology At NAB 2015
Tangible IP Announces Record Performance for 2014
3D Printing Session Added to Agenda At IP and Patent Strategy Conference
IQ4I Research & Consultancy Publishes A New Report on 'Patient Monitoring Global Market'
IPR Challenge Process to be Discussed at Medical Device and Diagnostic IP/Patent Strategy Conference
BananaIP to Launch A New IP Licensing & Commercialization Service
Brain League's Patent Partners Join BananaIP
Dr. Kalyan Kankanala to Deliver A Talk on Strategies for Increasing IP Numbers in A Company
BananaIP Announces Seminar on Business Approach to Intellectual Property for IT, Electronics and Telecom Industries
RTP’s Fuentek Receives High Honors at 2014 STC International Summit Awards

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today